The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...
Những tác giả chính: | Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D |
---|---|
Định dạng: | Conference item |
Được phát hành: |
Springer London
2018
|
Những quyển sách tương tự
-
The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
Bằng: Ali, M, et al.
Được phát hành: (2018) -
Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
Bằng: Ali, MS, et al.
Được phát hành: (2017) -
Oral bisphosphonates and chronic kidney disease: progression and safety
Bằng: Prieto-Alhambra, D, et al.
Được phát hành: (2018) -
Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
Bằng: Alarkawi, D, et al.
Được phát hành: (2018) -
Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
Bằng: Robinson, DE, et al.
Được phát hành: (2021)